Intensified Rituimab Prephase Before FCR in Untreated B-CLL
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
Phase II, multicenter, randomized trial, exploring intensified Rituximab prephase monotherapy
before standard Fludarabine-Cyclophosphamide-Rituximab FC-R regimen in previously untreated
symptomatic B-cell chronic lymphocytic leukemia CLL.
A Study from the Goelams GCFLLCMW intergroup